These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18755375)

  • 1. Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology.
    Kimball AB; Kupper TS
    Clin Dermatol; 2008; 26(5):554-61. PubMed ID: 18755375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis and immunotherapy of psoriasis.
    Griffiths TW; Griffiths CE; Voorhees JJ
    Dermatol Clin; 1995 Oct; 13(4):739-49. PubMed ID: 8785879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunology in clinical practice. VII. Psoriasis].
    Bos JD; de Rie MA
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2334-8. PubMed ID: 9550823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psoriasis: pathogenesis and treatment].
    Heenen M
    Rev Med Brux; 2003 Jun; 24(3):139-47. PubMed ID: 12891880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunology of psoriasis and biologic immunotherapy.
    Mehlis SL; Gordon KB
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S44-50. PubMed ID: 12894125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research.
    Guttman-Yassky E; Krueger JG
    Br J Dermatol; 2007 Dec; 157(6):1103-15. PubMed ID: 17714560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis.
    Nestle FO
    Curr Dir Autoimmun; 2008; 10():65-75. PubMed ID: 18460881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted against T-cells: immunomodulators in psoriasis].
    Mader U
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1640. PubMed ID: 12931726
    [No Abstract]   [Full Text] [Related]  

  • 9. Guttate and plaque psoriasis.
    Christophers E; Kiene P
    Dermatol Clin; 1995 Oct; 13(4):751-6. PubMed ID: 8785880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunotherapies for psoriasis.
    Asadullah K; Volk HD; Sterry W
    Trends Immunol; 2002 Jan; 23(1):47-53. PubMed ID: 11801454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of phototherapy on the numbers of circulating natural killer cells and T lymphocytes in psoriasis.
    Tobin AM; Maguire B; Enright H; Kirby B
    Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):109-10. PubMed ID: 19292789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating psoriasis as a T-cell mediated disease.
    Leonardi C
    Manag Care; 2004 Apr; 13(4 Suppl Treating Psoriasis):1, 3-8. PubMed ID: 15282980
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological mechanisms involved in psoriasis.
    Griffiths CE; Voorhees JJ
    Springer Semin Immunopathol; 1992; 13(3-4):441-54. PubMed ID: 1411908
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sorption therapy of psoriasis and indicators of the immune system during treatment].
    Nesterenko GB; Usenko LV; Bashmakov GV; Kogon GKh; Ploskaia LM
    Vestn Dermatol Venerol; 1985 Oct; (10):41-4. PubMed ID: 3878638
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigens from Leishmania amastigotes induced clinical remission of psoriasis.
    O'Daly JA; Lezama R; Rodriguez PJ; Silva E; Indriago NR; Peña G; Colorado I; Gleason J; Rodríguez B; Acuña L; Ovalles T
    Arch Dermatol Res; 2009 Jan; 301(1):1-13. PubMed ID: 18777031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis: from gene to clinic.
    Izco-Basurko I
    Drug News Perspect; 2009 Apr; 22(3):177-9. PubMed ID: 19440561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effector function of CLA(+) T lymphocytes on autologous keratinocytes in psoriasis].
    Ferran M; Giménez-Arnau AM; Bellosillo B; Pujol RM; Santamaría-Babi LF
    Actas Dermosifiliogr; 2008 Nov; 99(9):701-7. PubMed ID: 19087808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating new therapies for psoriasis.
    Morrow T
    Manag Care; 2004 Oct; 13(10):34-40. PubMed ID: 15535158
    [No Abstract]   [Full Text] [Related]  

  • 20. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.